Literature DB >> 9493081

The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice.

T Matsuzaki1, R Yamazaki, S Hashimoto, T Yokokura.   

Abstract

We investigated the effect of oral feeding of heat-killed Lactobacillus casei strain Shirota on immunoglobulin E (IgE) production in mice. The strain was orally administered to BALB/c mice that had been preinjected intraperitoneally with ovalbumin, and the level of IgE in serum was determined. Results indicated that the oral feeding of L. casei strain Shirota was effective in inhibiting IgE production in serum, and the IgE production in response to ovalbumin was significantly inhibited in the mice. The in vitro production of IgE by the spleen cells from mice fed L. casei strain Shirota in response to restimulation with ovalbumin was inhibited in contrast to that of spleen cells from the control group. We also examined the pattern of cytokine production by spleen cells from mice fed L. casei strain Shirota followed by restimulation with ovalbumin in vitro. In the mice fed L. casei strain Shirota, the production by the spleen cells of Th1 cell-associated cytokines, such as interferon-gamma and interleukin-2, was higher than that by the spleen cells from the control group. In contrast, the production of Th2 cell-associated cytokines, such as interleukin-4, interleukin-5, interleukin-6, and interleukin-10, by spleen cells in the group fed L. casei strain Shirota was lower than that by the cells from the control group. Furthermore, the interleukin-12 production of the spleen cells from mice fed L. casei strain Shirota was also higher than that of the control group.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493081     DOI: 10.3168/jds.S0022-0302(98)75549-3

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  29 in total

Review 1.  The influence of yogurt/Lactobacillus on the innate and acquired immune response.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

2.  Antimicrobial activity of intraurethrally administered probiotic Lactobacillus casei in a murine model of Escherichia coli urinary tract infection.

Authors:  T Asahara; K Nomoto; M Watanuki; T Yokokura
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination.

Authors:  Michael de Vrese; Peter Rautenberg; Christiane Laue; Marion Koopmans; Tineke Herremans; Jürgen Schrezenmeir
Journal:  Eur J Nutr       Date:  2004-12-01       Impact factor: 5.614

4.  Chondroitin sulfate intake inhibits the IgE-mediated allergic response by down-regulating Th2 responses in mice.

Authors:  Shinobu Sakai; Hiroshi Akiyama; Yuji Sato; Yasuo Yoshioka; Robert J Linhardt; Yukihiro Goda; Tamio Maitani; Toshihiko Toida
Journal:  J Biol Chem       Date:  2006-04-19       Impact factor: 5.157

5.  Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model.

Authors:  N Takahashi; H Kitazawa; N Iwabuchi; J Z Xiao; K Miyaji; K Iwatsuki; T Saito
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

6.  Effect of special Hungarian probiotic kefir on faecal microflora.

Authors:  Mária Figler; Gyula Mózsik; Béla Schaffer; Beáta Gasztonyi; Pongrác Acs; Béla Szili; Regina Rab; Sándor Szakály
Journal:  World J Gastroenterol       Date:  2006-02-21       Impact factor: 5.742

Review 7.  Strategies of mucosal immunotherapy for allergic diseases.

Authors:  Yi-Ling Ye; Ya-Hui Chuang; Bor-Luen Chiang
Journal:  Cell Mol Immunol       Date:  2011-06-13       Impact factor: 11.530

8.  Probiotics: Potent Immunomodulatory Tool Against Allergy.

Authors:  Umesh Kr Shandilya; Sagar Jadhav; Vandana Panwar; V K Kansal
Journal:  Probiotics Antimicrob Proteins       Date:  2011-12       Impact factor: 4.609

9.  Probiotics and small bowel mucosa: Molecular aspects of their interactions.

Authors:  N Saulnier; M A Zocco; S Di Caro; G Gasbarrini; A Gasbarrini
Journal:  Genes Nutr       Date:  2006-06       Impact factor: 5.523

10.  Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?

Authors:  P V Kirjavainen; T Arvola; S J Salminen; E Isolauri
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.